These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33486889)

  • 1. Update of genetic variants in CEP120 and CC2D2A-With an emphasis on genotype-phenotype correlations, tissue specific transcripts and exploring mutation specific exon skipping therapies.
    Barroso-Gil M; Olinger E; Ramsbottom SA; Molinari E; Miles CG; Sayer JA
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1603. PubMed ID: 33486889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in CEP120 cause Joubert syndrome as well as complex ciliopathy phenotypes.
    Roosing S; Romani M; Isrie M; Rosti RO; Micalizzi A; Musaev D; Mazza T; Al-Gazali L; Altunoglu U; Boltshauser E; D'Arrigo S; De Keersmaecker B; Kayserili H; Brandenberger S; Kraoua I; Mark PR; McKanna T; Van Keirsbilck J; Moerman P; Poretti A; Puri R; Van Esch H; Gleeson JG; Valente EM
    J Med Genet; 2016 Sep; 53(9):608-15. PubMed ID: 27208211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-phenotype correlation in CC2D2A-related Joubert syndrome reveals an association with ventriculomegaly and seizures.
    Bachmann-Gagescu R; Ishak GE; Dempsey JC; Adkins J; O'Day D; Phelps IG; Gunay-Aygun M; Kline AD; Szczaluba K; Martorell L; Alswaid A; Alrasheed S; Pai S; Izatt L; Ronan A; Parisi MA; Mefford H; Glass I; Doherty D
    J Med Genet; 2012 Feb; 49(2):126-37. PubMed ID: 22241855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CC2D2A mutations in Meckel and Joubert syndromes indicate a genotype-phenotype correlation.
    Mougou-Zerelli S; Thomas S; Szenker E; Audollent S; Elkhartoufi N; Babarit C; Romano S; Salomon R; Amiel J; Esculpavit C; Gonzales M; Escudier E; Leheup B; Loget P; Odent S; Roume J; Gérard M; Delezoide AL; Khung S; Patrier S; Cordier MP; Bouvier R; Martinovic J; Gubler MC; Boddaert N; Munnich A; Encha-Razavi F; Valente EM; Saad A; Saunier S; Vekemans M; Attié-Bitach T
    Hum Mutat; 2009 Nov; 30(11):1574-82. PubMed ID: 19777577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AON-Mediated Exon Skipping to Bypass Protein Truncation in Retinal Dystrophies Due to the Recurrent
    Barny I; Perrault I; Michel C; Goudin N; Defoort-Dhellemmes S; Ghazi I; Kaplan J; Rozet JM; Gerard X
    Genes (Basel); 2019 May; 10(5):. PubMed ID: 31091803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole exome sequencing identified a novel missense alteration in CC2D2A causing Joubert syndrome 9 in a Pakhtun family.
    Khan MI; Latif M; Saif M; Ahmad H; Khan AU; Naseer MI; Hussain HMJ; Jelani M
    J Gene Med; 2021 Jan; 23(1):e3279. PubMed ID: 32989887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Molecular Diagnosis of Joubert Syndrome and Related Disorders.
    Radha Rama Devi A; Naushad SM; Lingappa L
    Pediatr Neurol; 2020 May; 106():43-49. PubMed ID: 32139166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision Medicine through Antisense Oligonucleotide-Mediated Exon Skipping.
    Li D; Mastaglia FL; Fletcher S; Wilton SD
    Trends Pharmacol Sci; 2018 Nov; 39(11):982-994. PubMed ID: 30282590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing the morbid genome of ciliopathies.
    Shaheen R; Szymanska K; Basu B; Patel N; Ewida N; Faqeih E; Al Hashem A; Derar N; Alsharif H; Aldahmesh MA; Alazami AM; Hashem M; Ibrahim N; Abdulwahab FM; Sonbul R; Alkuraya H; Alnemer M; Al Tala S; Al-Husain M; Morsy H; Seidahmed MZ; Meriki N; Al-Owain M; AlShahwan S; Tabarki B; Salih MA; ; Faquih T; El-Kalioby M; Ueffing M; Boldt K; Logan CV; Parry DA; Al Tassan N; Monies D; Megarbane A; Abouelhoda M; Halees A; Johnson CA; Alkuraya FS
    Genome Biol; 2016 Nov; 17(1):242. PubMed ID: 27894351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal exon skipping and genetic pleiotropy: A predictive model of disease pathogenesis.
    Drivas TG; Wojno AP; Tucker BA; Stone EM; Bennett J
    Sci Transl Med; 2015 Jun; 7(291):291ra97. PubMed ID: 26062849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CC2D2A is mutated in Joubert syndrome and interacts with the ciliopathy-associated basal body protein CEP290.
    Gorden NT; Arts HH; Parisi MA; Coene KL; Letteboer SJ; van Beersum SE; Mans DA; Hikida A; Eckert M; Knutzen D; Alswaid AF; Ozyurek H; Dibooglu S; Otto EA; Liu Y; Davis EE; Hutter CM; Bammler TK; Farin FM; Dorschner M; Topçu M; Zackai EH; Rosenthal P; Owens KN; Katsanis N; Vincent JB; Hildebrandt F; Rubel EW; Raible DW; Knoers NV; Chance PF; Roepman R; Moens CB; Glass IA; Doherty D
    Am J Hum Genet; 2008 Nov; 83(5):559-71. PubMed ID: 18950740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the phenotypic spectrum of CC2D2A-related ciliopathies: a rare homozygous nonsense variant in a patient with suspected nephronophthisis.
    Sentell ZT; Nurcombe ZW; Mougharbel L; Anastasio N; Rivière JB; Babayeva S; Goodyer PR; Torban E; Kitzler TM
    Eur J Hum Genet; 2024 Sep; 32(9):1184-1189. PubMed ID: 38987663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression patterns of ciliopathy genes ARL3 and CEP120 reveal roles in multisystem development.
    Powell L; Barroso-Gil M; Clowry GJ; Devlin LA; Molinari E; Ramsbottom SA; Miles CG; Sayer JA
    BMC Dev Biol; 2020 Dec; 20(1):26. PubMed ID: 33297941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole exome sequencing resolves complex phenotype and identifies CC2D2A mutations underlying non-syndromic rod-cone dystrophy.
    Méjécase C; Hummel A; Mohand-Saïd S; Andrieu C; El Shamieh S; Antonio A; Condroyer C; Boyard F; Foussard M; Blanchard S; Letexier M; Saraiva JP; Sahel JA; Zeitz C; Audo I
    Clin Genet; 2019 Feb; 95(2):329-333. PubMed ID: 30267408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
    Echigoya Y; Lim KRQ; Trieu N; Bao B; Miskew Nichols B; Vila MC; Novak JS; Hara Y; Lee J; Touznik A; Mamchaoui K; Aoki Y; Takeda S; Nagaraju K; Mouly V; Maruyama R; Duddy W; Yokota T
    Mol Ther; 2017 Nov; 25(11):2561-2572. PubMed ID: 28865998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Exon-Skipping Therapeutic Approach for the DMD Gene Based on Asymptomatic Deletions of Exon 49.
    Abaji M; Gorokhova S; Da Silva N; Busa T; Grelet M; Missirian C; Sigaudy S; Philip N; Leturcq F; Lévy N; Krahn M; Bartoli M
    Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meckel Gruber and Joubert Syndrome Diagnosed Prenatally: Allelism between the Two Ciliopathies, Complexities of Mutation Types and Digenic Inheritance.
    Srivastava S; Manisha R; Dwivedi A; Agarwal H; Saxena D; Agrawal V; Mandal K
    Fetal Pediatr Pathol; 2022 Dec; 41(6):1041-1051. PubMed ID: 34821546
    [No Abstract]   [Full Text] [Related]  

  • 18. Spectrum and frequencies of extraocular features reported in CEP290-associated ciliopathy - A systematic review.
    Vrabič N; Fakin A; Tekavčič Pompe M
    J Fr Ophtalmol; 2024 Oct; 47(8):104232. PubMed ID: 39213781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy.
    Yokota T; Pistilli E; Duddy W; Nagaraju K
    Expert Opin Biol Ther; 2007 Jun; 7(6):831-42. PubMed ID: 17555369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The assembly and evaluation of antisense oligonucleotides applied in exon skipping for titin-based mutations in dilated cardiomyopathy.
    Hahn JK; Neupane B; Pradhan K; Zhou Q; Testa L; Pelzl L; Maleck C; Gawaz M; Gramlich M
    J Mol Cell Cardiol; 2019 Jun; 131():12-19. PubMed ID: 30998980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.